{"id":"NCT03337542","sponsor":"Aimmune Therapeutics, Inc.","briefTitle":"AR101 Real-World Open-Label Extension Study","officialTitle":"Real-World AR101 Market-Supporting Experience Study in Peanut-Allergic Children, Active Treatment Arm Open-Label Extension Study (RAMSES OLE)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-10-18","primaryCompletion":"2019-09-20","completion":"2019-09-20","firstPosted":"2017-11-09","resultsPosted":"2021-11-02","lastUpdate":"2021-11-02"},"enrollment":243,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Peanut Allergy"],"interventions":[{"type":"BIOLOGICAL","name":"AR101","otherNames":[]}],"arms":[{"label":"Treatment arm description","type":"OTHER"}],"summary":"This study is enrolling participants by invitation only. This is an open-label, safety extension study for subjects who participated in the ARC007 study.","primaryOutcome":{"measure":"Number of Participants With Treatment-Emergent Adverse Events (Safety and Tolerability)","timeFrame":"Approximately 6 months","effectByArm":[{"arm":"AR101","deltaMin":219,"sd":null}],"pValues":[]},"eligibility":{"minAge":"4 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":4},"locations":{"siteCount":60,"countries":["United States","Canada"]},"refs":{"pmids":["34389504"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":242},"commonTop":["Cough","Abdominal discomfort","Throat irritation","Upper respiratory tract infection","Pruritus"]}}